Zynex, Inc.
Index- P/E16.43 EPS (ttm)0.49 Insider Own39.70% Shs Outstand39.77M Perf Week-9.58%
Market Cap307.25M Forward P/E12.43 EPS next Y0.65 Insider Trans0.00% Shs Float21.29M Perf Month11.23%
Income19.20M PEG- EPS next Q0.07 Inst Own38.40% Short Float23.20% Perf Quarter29.77%
Sales137.30M P/S2.24 EPS this Y84.80% Inst Trans13.53% Short Ratio10.16 Perf Half Y-14.97%
Book/sh1.91 P/B4.20 EPS next Y48.28% ROA17.50% Target Price17.19 Perf Year-43.89%
Cash/sh1.02 P/C7.84 EPS next 5Y- ROE28.40% 52W Range4.97 - 16.10 Perf YTD-10.62%
Dividend- P/FCF30.72 EPS past 5Y193.30% ROI19.00% 52W High-50.19% Beta0.81
Dividend %- Quick Ratio3.10 Sales past 5Y57.80% Gross Margin79.60% 52W Low61.37% ATR0.63
Employees774 Current Ratio3.70 Sales Q/Q29.00% Oper. Margin18.50% RSI (14)54.92 Volatility12.50% 8.38%
OptionableYes Debt/Eq0.20 EPS Q/Q281.50% Profit Margin14.00% Rel Volume0.43 Prev Close8.02
ShortableYes LT Debt/Eq0.13 EarningsApr 28 AMC Payout0.00% Avg Volume486.26K Price8.02
Recom2.00 SMA205.64% SMA5011.92% SMA200-6.62% Volume208,478 Change0.00%
Feb-28-22Reiterated B. Riley Securities Buy $15.50 → $10
Jul-16-21Upgrade B. Riley Securities Neutral → Buy $19.50
Jul-16-21Upgrade B. Riley Securities Neutral → Buy $19 → $19.50
Mar-09-21Upgrade Northland Capital Market Perform → Outperform $22.50
Feb-26-21Downgrade B. Riley Securities Buy → Neutral $19
Jan-29-21Downgrade Piper Sandler Overweight → Neutral $28 → $20
Jan-28-21Downgrade Northland Capital Outperform → Market Perform $22.50
Sep-14-20Upgrade H.C. Wainwright Neutral → Buy $25
Sep-09-20Upgrade Northland Capital Market Perform → Outperform $22.50
Jul-29-20Upgrade B. Riley FBR Neutral → Buy $28
Jul-20-20Initiated Piper Sandler Overweight $30
Jul-13-20Downgrade B. Riley FBR Buy → Neutral
Jul-10-20Reiterated H.C. Wainwright Neutral $20 → $30
Jun-16-20Downgrade Northland Capital Outperform → Market Perform
May-19-20Downgrade H.C. Wainwright Buy → Neutral $20
Apr-01-20Initiated Northland Capital Outperform $15
Sep-23-19Initiated H.C. Wainwright Buy $12
Jun-15-22 09:36AM  
Jun-13-22 04:30PM  
Jun-09-22 09:00AM  
May-27-22 07:29AM  
May-13-22 06:53AM  
May-10-22 07:00AM  
May-03-22 07:00AM  
Apr-28-22 05:25PM  
Apr-25-22 12:27PM  
Apr-18-22 07:00AM  
Apr-11-22 09:15AM  
Apr-08-22 07:00AM  
Mar-29-22 12:37PM  
Mar-23-22 07:01AM  
Feb-27-22 07:43AM  
Feb-24-22 05:50PM  
Feb-18-22 07:00AM  
Feb-08-22 04:04PM  
Jan-20-22 07:04AM  
Jan-18-22 09:00AM  
Jan-12-22 09:38PM  
Jan-11-22 09:00AM  
Jan-06-22 12:22PM  
Jan-05-22 09:00AM  
Jan-03-22 09:00AM  
Dec-30-21 04:54PM  
Dec-23-21 09:00AM  
Dec-20-21 09:15AM  
Nov-24-21 04:05PM  
Nov-22-21 01:58PM  
Nov-18-21 09:15AM  
Nov-10-21 09:15AM  
Nov-03-21 09:15AM  
Nov-02-21 09:01PM  
Oct-25-21 09:15AM  
Oct-20-21 09:10AM  
Oct-13-21 09:15AM  
Oct-08-21 09:15AM  
Jul-30-21 02:02AM  
Jul-29-21 06:25PM  
Jul-21-21 09:15AM  
Jul-16-21 07:12AM  
Jul-15-21 09:15AM  
Jul-14-21 08:39AM  
Jul-13-21 09:15AM  
Jul-08-21 09:15AM  
Jun-30-21 10:08AM  
Apr-30-21 05:30AM  
Apr-29-21 06:15PM  
Apr-20-21 09:15AM  
Apr-19-21 09:15AM  
Apr-12-21 09:15AM  
Apr-09-21 09:15AM  
Apr-08-21 10:53AM  
Mar-30-21 09:15AM  
Mar-09-21 02:45AM  
Mar-08-21 09:15AM  
Feb-26-21 12:12PM  
Feb-25-21 05:35PM  
Feb-18-21 09:15AM  
Feb-04-21 06:49AM  
Feb-03-21 12:47PM  
Jan-28-21 04:30PM  
Jan-14-21 09:15AM  
Jan-12-21 09:00AM  
Jan-06-21 09:15AM  
Dec-31-20 04:11AM  
Dec-30-20 05:00AM  
Dec-10-20 09:40PM  
Dec-01-20 05:34AM  
Nov-19-20 09:15AM  
Nov-17-20 09:15AM  
Oct-29-20 03:07PM  
Oct-27-20 08:31PM  
Oct-23-20 09:15AM  
Oct-20-20 09:15AM  
Oct-13-20 02:38AM  
Oct-12-20 11:35AM  
Oct-06-20 09:15AM  
Sep-23-20 02:42PM  
Sep-14-20 10:16AM  
Sep-10-20 09:00AM  
Sep-04-20 12:01PM  
Sep-03-20 09:00AM  
Aug-26-20 12:27PM  
Aug-16-20 06:22AM  
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandgaard ThomasPresident, CEO and ChairmanAug 06Sale15.17177,3202,689,82013,617,420Aug 10 06:39 PM